| Serial Number | 98117544 |
| Word Mark | B |
| Filing Date | Friday, August 4, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Friday, April 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of a stylized capital letter B. |
| Goods and Services | Medicines for human purposes; medicinal agents for human use; anti-inflammatories; antiulcer drugs; biological preparations for medical purposes; chemical preparations for medical purposes; opotherapy preparations; detergents for medical purposes; depurative; pharmaceutical drugs; pharmaceutical preparations |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, September 3, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Buffalo Biomedical Technology Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Taipei City 110410 TW |
| Event Date | Event Description |
| Friday, April 5, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, August 8, 2023 | NEW APPLICATION ENTERED |
| Sunday, September 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 19, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, April 19, 2024 | NON-FINAL ACTION E-MAILED |